Various Baxter Healthcare Products Recalled

On Aug. 7, 2026, Baxter Healthcare Corporation initiated a voluntary recall of selected lots of Myxredlin® (insulin human), Cardene IV® (nicardipine hydrochloride), Nexterone® (amiodarone HCl), and multiple injectable famotidine, clindamycin, dexmedetomidine, vasopressin, vancomycin, pantoprazole, and daptomycin products due to the potential for contamination with a beta-lactam drug product. Products containing beta-lactam compounds may cause allergic reactions, including severe and potentially life-threatening hypersensitivity reactions, in individuals with beta-lactam allergies. For additional information regarding affected products, lot numbers and expiration dates, see the manufacturer's recall notice here.